%0 Journal Article
%T Prevalence of Human Leukocyte Antigen HLA-B*5701 in HIV-1 Infected Individuals in Brazil
%A Claudin¨¦ia de Ara¨˛jo
%A Cristina Valetta de Carvalho
%A Miriam Estela de Souza Freire
%A Amanda Yamaguti
%A Ivens Cuiabano Scaff
%A Fernando Jos¨¦ de Souza
%A Fl¨˘via Galindo Silvestre Silva
%A Ricardo Sobhie Diaz
%A Ismael Dale Cotrim Guerreiro da Silva
%J Open Journal of Genetics
%P 56-62
%@ 2162-4461
%D 2014
%I Scientific Research Publishing
%R 10.4236/ojgen.2014.41008
%X <p style=\"text-align:justify;\">
	<span style=\"font-size:10.0pt;line-height:97%;font-family:;\" \"=\"\"><span style=\"font-family:Verdana;line-height:1.5;\"> </span></span>
</p>
<p style=\"text-align:justify;\">
	This study was designed to establish the prevalence of
HLA-B*5701 at HIV-1 infected individuals in Brazil. A total of 517 consecutive
individuals were followed in this study from February 2009 through July 2011. The presence of HLA-B*5701 was
determined by Nested-PCR with HLA-B*57 and HLA-B*5701 sequence-specific primers (PCR-SSP). The expression of
HLA-B*57 was negative in the 385 (74.5%) and positive in the
103 (19.9%) of infected
individuals. Among these, the expression of HLA-B5701
was positive in the 29 (5.6%) of individuals. No demographic or ethnic
differences were found between HLA-B*57/HLA-B*5701
HIV-1 negative patients, with a prevalence of Caucasians (57.1%) individuals.
During the period
of study, 68 patients were submited to an abacavir contain- ing regimen. The HLA-B*5701
allele was observed in 7 (10.3%)
patients, with a significant incidence of Hypersensitivity reactions at 4 of them (p &lt; 0.001). Conclusions:
Although Brazilian population consists of a
mixture of individuals of Caucasian, African and Native American genetic
background, prevalence of HLA-B*5701 in this population is similar to the one
found in pure Caucasians.
</p>
<span style=\"font-size:10.0pt;line-height:97%;font-family:;\" \"=\"\"><span style=\"font-family:Verdana;line-height:1.5;\"></span><span style=\"font-family:Verdana;line-height:1.5;\"></span></span> 
<p>
	<br />
</p>
%K Immunogenetics
%K Human Immunodeficiency Virus
%K HLA-B*5701 Antigen Human
%K Abacavir
%U http://www.scirp.org/journal/PaperInformation.aspx?PaperID=44039